The patient's weight is (b)(6).The complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.However, the complainant reported that the device was not expired.(b)(4).The complainant indicated that the device remains implanted and will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
|
It was reported to boston scientific corporation on march 19, 2016 that a wallflex¿ esophageal stent was implanted in the esophagus during an esophagogastroduodenoscopy (egd) with stent placement procedure performed on (b)(6) 2016.According to the complainant, the stent was to be used to treat a malignant stricture caused by cancer in the distal esophagus.Reportedly, the patient¿s anatomy was not tortuous and had not been dilated prior to stent placement procedure.According to the complainant, the wallflex¿ esophageal stent migrated approximately 2cm distally into the stomach.Reportedly, the patient initially felt discomfort and, on (b)(6) 2016, an x-ray was performed and migration was confirmed.On (b)(6) 2016, the patient¿s discomfort subsided and the physician decided to leave the stent in place.There were no patient complications reported as a result of this event.The patient's current condition was reported to be okay.
|